Fonte: Brazilian Journal of Medical and Biological Research. Unidade: FMRP
Assuntos: MANIFESTAÇÕES NEUROLÓGICAS, ENZIMAS GLICOLÍTICAS, LÍQUIDO CEFALORRAQUIDIANO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, J. E. et al. Use of neuron-specific enolase for assessing the severity and outcome in patients with neurological disorders. Brazilian Journal of Medical and Biological Research, v. 37, p. 19-26, 2004Tradução . . Disponível em: http://www.scielo.br/pdf/bjmbr/v37n1/5349.pdf. Acesso em: 12 set. 2024.APA
Lima, J. E., Takayanagui, O. M., Garcia, L. V., & Leite, J. P. (2004). Use of neuron-specific enolase for assessing the severity and outcome in patients with neurological disorders. Brazilian Journal of Medical and Biological Research, 37, 19-26. Recuperado de http://www.scielo.br/pdf/bjmbr/v37n1/5349.pdfNLM
Lima JE, Takayanagui OM, Garcia LV, Leite JP. Use of neuron-specific enolase for assessing the severity and outcome in patients with neurological disorders [Internet]. Brazilian Journal of Medical and Biological Research. 2004 ; 37 19-26.[citado 2024 set. 12 ] Available from: http://www.scielo.br/pdf/bjmbr/v37n1/5349.pdfVancouver
Lima JE, Takayanagui OM, Garcia LV, Leite JP. Use of neuron-specific enolase for assessing the severity and outcome in patients with neurological disorders [Internet]. Brazilian Journal of Medical and Biological Research. 2004 ; 37 19-26.[citado 2024 set. 12 ] Available from: http://www.scielo.br/pdf/bjmbr/v37n1/5349.pdf
